Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Hossein Khalili and Effat Davoudi-Monfared.
Hossein Khalili
Connection Strength
1.272
Effat Davoudi-Monfared
  1. Reply to Dorgham et al., "Considering Personalized Interferon Beta Therapy for COVID-19". Antimicrob Agents Chemother. 2021 03 18; 65(4).
    View in: PubMed
    Score: 0.935
  2. A Randomized Clinical Trial of the Efficacy and Safety of Interferon ß-1a in Treatment of Severe COVID-19. Antimicrob Agents Chemother. 2020 08 20; 64(9).
    View in: PubMed
    Score: 0.225
  3. Comparing outcomes of hospitalized patients with moderate and severe COVID-19 following treatment with hydroxychloroquine plus atazanavir/ritonavir. Daru. 2020 Dec; 28(2):625-634.
    View in: PubMed
    Score: 0.056
  4. Interferon ß-1b in treatment of severe COVID-19: A randomized clinical trial. Int Immunopharmacol. 2020 Nov; 88:106903.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.